2型糖尿病脑灌注与底物代谢改变及其与APOE-ε4的交互作用
该探索性研究纳入38名参与者(2型糖尿病10例、超重13例、瘦对照15例),采用多种影像技术评估脑代谢。2型糖尿病与脑灌注及葡萄糖摄取降低、白质脂肪酸摄取升高相关,脂肪酸摄取升高也见于APOE-ε4携带者。
要点
- 2型糖尿病组脑葡萄糖摄取低于瘦组和超重组(p<0.01)。
- 2型糖尿病组和超重组脑灌注均低于瘦对照组(p<0.01)。
- 糖尿病组白质脂肪酸摄取高于瘦组(p<0.05),APOE-ε4携带者亦升高。
核心结论
- 2型糖尿病与脑灌注及葡萄糖摄取降低、白质脂肪酸摄取升高相关;作者认为靶向脑代谢功能障碍尤其是脂肪酸代谢可能是降低神经退行性变风险的潜在策略。
研究设计与样本
- 探索性研究纳入38名参与者:2型糖尿病10例、超重13例、瘦对照15例。
- 采用[18F]氟脱氧葡萄糖和[18F]氟-6-硫代十七烷酸正电子发射断层扫描评估葡萄糖和脂肪酸摄取;动脉自旋标记MRI评估脑灌注;1H-磁共振波谱评估特定代谢物;腰椎穿刺样本评估神经退行性变标志物。
- 组间比较采用单因素方差分析和非配对t检验,相关性采用线性回归评估。
主要发现
- 2型糖尿病组脑葡萄糖摄取低于瘦组和超重组(p<0.01)。
- 2型糖尿病组和超重组脑灌注均低于瘦对照组(p<0.01)。
- 葡萄糖摄取和灌注均与HOMA-IR、胰岛素和HbA1c水平呈负相关(p<0.001-p<0.05)。
- 糖尿病组白质脂肪酸摄取高于瘦组(p<0.05)。
- 事后分析显示瘦型APOE-ε4携带者全脑脂肪酸摄取高于瘦型非携带者;非携带者中2型糖尿病者脂肪酸摄取高于瘦对照(p<0.01-p<0.05),且与HOMA-IR、胰岛素和HbA1c呈正相关(p<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Epidemiological studies indicate that type 2 diabetes increases the risk for Alzheimer's disease. Alterations in cerebral metabolism have been proposed as a potential mechanism underlying this association. A better understanding of these metabolic changes may elucidate potential pathways linking type 2 diabetes to Alzheimer's disease. The aim of the current exploratory study was to investigate whether cerebral metabolism, including glucose and fatty acid uptake as well as cerebral blood flow, is altered in individuals with type 2 diabetes compared with both overweight individuals and lean control individuals. METHODS: This exploratory study included 38 participants (ten with type 2 diabetes, 13 overweight individuals and 15 lean control individuals). Brain metabolism was assessed using multiple imaging techniques: [18F]fluorodeoxyglucose and [18F]fluoro-6-thiaheptadecanoic acid positron emission tomography for glucose and fatty acid uptake; arterial spin-labelling MRI for cerebral perfusion; and 1H-magnetic resonance spectroscopy for specific metabolites. Neurodegeneration markers were evaluated from lumbar puncture samples. Group comparisons were assessed using one-way ANOVA and unpaired t tests, and correlations were assessed with linear regression. RESULTS: Individuals with type 2 diabetes exhibited lower cerebral glucose uptake compared with both lean and overweight groups (p<0.01). Cerebral perfusion was reduced in both participants with type 2 diabetes and overweight participants relative to lean control participants (p<0.01). Both glucose uptake and perfusion correlated negatively with HOMA-IR, insulin and HbA1c levels (p<0.001-p<0.05). White matter fatty acid uptake was elevated in the diabetes group compared with the lean group (p<0.05). Post hoc analyses revealed that lean APOE-ε4 carriers had increased fatty acid uptake in the entire brain relative to lean non-carriers. Among non-carriers of APOE-ε4, those with type 2 diabetes showed higher fatty acid uptake than lean control individuals (p<0.01-p<0.05), and this uptake correlated positively with HOMA-IR, insulin and HbA1c levels (p<0.05). CONCLUSIONS/INTERPRETATION: Type 2 diabetes was associated with decreased cerebral perfusion and glucose uptake but increased fatty acid uptake in white matter. The elevated fatty acid uptake observed both in individuals with type 2 diabetes and in APOE-ε4 carriers suggests a common metabolic dysfunction for these Alzheimer's disease risk factors and suggests that targeting cerebral metabolic dysfunction, particularly fatty acid metabolism, could be a potential strategy for reducing the risk for neurodegeneration in individuals with type 2 diabetes.
引用
- Schain M, Johansson E, Laitinen I, et al. Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4. Diabetologia. 2025. PMID: 40214756. doi:10.1007/s00125-025-06405-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。